Rigel Pharmaceuticals (RIGL) Capital Leases (2010 - 2016)

Rigel Pharmaceuticals' Capital Leases history runs 4 years deep, the most recent figure standing at $238000.0 for Q4 2016.

• In Q4 2016, Capital Leases fell 93.12% year-over-year to $238000.0; the TTM figure through Dec 2016 stood at $238000.0 (down 93.12% YoY), while the FY2016 annual figure was $238000.0, down 93.12% from the prior year.
• Capital Leases was $238000.0 for Q4 2016 at Rigel Pharmaceuticals, down from $1.1 million in the prior quarter.
• In the past five years, Capital Leases ranged from a high of $6.5 million in Q4 2014 to a low of $238000.0 in Q4 2016.
• Historically, Capital Leases has averaged $3.4 million across 3 years, with a median of $3.5 million in 2015.
• The sharpest annual moves came in 2015 and 2016: Capital Leases sank 46.49% in 2015, then sank 93.12% in 2016.
• A 3-year view of Capital Leases shows it stood at $6.5 million in 2014, then tumbled by 46.49% to $3.5 million in 2015, then slumped by 93.12% to $238000.0 in 2016.
• The last three Capital Leases figures came in at $238000.0 (Q4 2016), $1.1 million (Q3 2016), and $1.9 million (Q2 2016), per Business Quant data.